Biogen is cutting 2022 expenses for Q2, profit forecast is raised
July 20, 2022 at 15:57 PM EDT
Biogen's second quarter expectations were soundly exceeded. Biogen was able to do this by slashing spending on the controversial drug Aduhelm.
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
